Skip to main content

Advertisement

SpringerLink
Log in

Technetium-99m MIBI single photon emission computed tomography as an indicator of prognosis for patients with lung cancer —Preliminaly report—

  • Original Article
  • Published:
Annals of Nuclear Medicine Aims and scope Submit manuscript

Abstract

Purpose: We performed technetium-99m hexakis-2-methoxyisobutylisonitrile (Tc-99m MIBI) single photon emission computed tomography (SPECT) in 23 patients with primary lung cancer between July 1993 and March 1996. We evaluated the relationships among the uptake ratio, retention index and the prognosis after radiation therapy and/or chemotherapy.Materials and Methods: Tc-99m MIBI SPECT was performed at 30 minutes and at 3 hours after intravenous injection of 600 MBq of Tc-99m MIBI with three gamma camera detectors (GCA-9300A/HG) on transverse SPECT images. Regions of interest were set in the area of abnormal uptake of Tc-99m MIBI and in the contralateral normal lung. The ratio of uptake in the lesion to that in the contralateral normal lung was obtained on early images (early ratio; ER) as well as delayed images (delayed ratio; DR). The retention index (RI) was calculated as follows: RI=(DR-ER)/ER×100. The ratio was compared with survival time and prognostic factors.Results: There was no correlation between ER and DR. The patients with high RI survived longer than those with low RI (median survival, 19.4 months vs. 9.4 months; p=0.0104 by the Mantel-Cox test).Conclusion: These results suggest that RI is the most useful among Tc-99m MIBI indices of primary lung cancer in predicting prognosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Holman BL, Jones AG, Lister-James J, Davison A, Abrams MJ, Kirshenbaum JM, et al. A new Tc-99m-labeled myocardial imaging agent, hexakis (t-butylisonitrile)technetium(I) [Tc-99m TBI]: initial experience in the human.J Nucl Med 25: 1350–1355, 1984.

    CAS  PubMed  Google Scholar 

  2. Wackers FJ, Berman DS, Maddahi J, Watson DD, Beller GA, Strauss HW, et al. Technetium-99m hexakis 2-methoxyisobutyl isonitrile: human biodistribution, dosimetry, safety, and preliminary comparison to thallium-201 for myocardial perfusion imaging.J Nucl Med 30: 301–311, 1989.

    CAS  PubMed  Google Scholar 

  3. Delmon-Moingeon LI, Piwnica-Worms D, Van den Abbeele AD, Holman BL, Davison A, Jones AG. Uptake of the Cation Hexakis(2-methoxyisobutylisonitrile)-Technetium-99m by Human Carcinoma Cell Linesin Vitro.Cancer Res 50: 2198–2202, 1990.

    CAS  PubMed  Google Scholar 

  4. Maublant JC, Zheng Z, Rapp M, Ollier M, Michelot J, Veyre A.In Vitro Uptake of Technetium-99m-Teboroxime in Carcinoma Cell Lines and Normal Cells: Comparison with Technetium-99m-Sestamibi and Thallium-201.J Nucl Med 34: 1949–1952, 1993.

    CAS  PubMed  Google Scholar 

  5. Chiu ML, Kronauge JF, Piwnica-Worms D. Effect of Mitochondrial and Plasma Membrane Potentials on Accumulation of Hexakis(2-Methoxyisobutylisonitrile) Technetium (I) in Cultured Mouse Fibroblasts.J Nucl Med 31: 1646–1653, 1990.

    CAS  PubMed  Google Scholar 

  6. Hassan IM, Sahweil A, Constantinides C, Mahmoud A, Nair M, Omar YT. Uptake and Kinetics of Tc-99m Hexakis 2-Methoxy Isobutyl Isonitrile in Benign and Malignant Lesions in the Lungs.Clin Nucl Med 14: 333–340, 1989.

    Article  CAS  PubMed  Google Scholar 

  7. Aktolun C, Bayhan H, Kir M. Clinical Experience with Tc-99m MIBI Imaging in Patients with Malignant Tumors: Preliminary Results and Comparison with Tl-201.Clin Nucl Med 17: 171–176, 1992.

    Article  CAS  PubMed  Google Scholar 

  8. Matsui R, Komori T, Narabayashi I, Namba R, Nakata Y, Tabuchi K, et al. Tc-99m Sestamibi Uptake by Malignant Lymphoma and Slow Washout.Clin Nucl Med 20: 352–356, 1995.

    Article  CAS  PubMed  Google Scholar 

  9. Kao CH, Wang SJ, Lin WY, Hsu CY, Liao SQ, Yeh SH. Differentiation of single solid lesions in the lungs by means of single-photon emission tomography with technetium-99m methoxyisobutylisonitrile.Eur J Nucl Med 20: 249–254, 1993.

    CAS  PubMed  Google Scholar 

  10. Strouse PJ, Wang DC. Incidental Detection of Bronchogenic Carcinoma During Tc-99m SESTAMIBI Cardiac Imaging.Clin Nucl Med 18: 448–449, 1993.

    Article  CAS  PubMed  Google Scholar 

  11. Bom HS, Kim YC, Song HC, Min JJ, Kim JY, Park KO. Technetium-99m-MIBI uptake in small cell lung cancer.J Nucl Med 39: 91–94, 1998.

    CAS  PubMed  Google Scholar 

  12. Nishiyama Y, Kawasaki Y, Yamamoto Y, Fukunaga K, Satoh K, Takashima H, et al. Technetium-99m-MIBI and thallium-201 scintigraphy of primary lung cancer.J Nucl Med 38: 1358–1361, 1997.

    CAS  PubMed  Google Scholar 

  13. Derebek E, Kirkali Z, Dogan AS, Degirmenci A, Yilmaz M, Igci E, et al.99mTc-MIBI scintigraphy in metastatic renal cell carcinoma: clinical validation of the relationship between99mTc-MIBI uptake and P-glycoprotein expression in tumour tissue.Eur J Nucl Med 23: 976–979, 1996.

    Article  CAS  PubMed  Google Scholar 

  14. Moretti JL, Duran Cordobes M, Starzec A, de Beco V, Vergote J, Benazzouz F, et al. Involvement of glutathione in loss of technetium-99m-MIBI accumulation related to membrane MDR protein expression in tumor cells.J Nucl Med 39: 1214–1218, 1998.

    CAS  PubMed  Google Scholar 

  15. Kostakoglu L, Guc D, Canpinar H, Kars A, Alper E, Kiratli P, et al. P-glycoprotein expression by technetium-99m-MIBI scintigraphy in hematologic malignancy.J Nucl Med 39: 1191–1197, 1998.

    CAS  PubMed  Google Scholar 

  16. Taki J, Sumiya H, Asada N, Ueda Y, Tsuchiya H, Tonami N. Assessment of P-glycoprotein in patients with malignant bone and soft-tissue tumors using technetium-99m-MIBI scintigraphy.J Nucl Med 39: 1179–1184, 1998.

    CAS  PubMed  Google Scholar 

  17. Kostakoglu L, Kiratli P, Ruacan S, et al. Association of tumor washout rates and accumulation of technetium-99m-MIBI with expression of P-glycoprotein in lung cancer.J Nucl Med 39: 228–234, 1998.

    CAS  PubMed  Google Scholar 

  18. Nishiyama Y, Yamamoto Y, Takahashi K, Satoh K, Takashima H, Ohkawa M, et al. Comparison of Tc-99m MIBI with Tl-201 in the evaluation of radiotherapy for primary lung cancer. 38: 299P, 1997.

  19. UICC:TNM classification of Malignant Tumors, 4th eds. Berlin Heidelberg New York London Paris Tokyo: Springer, 1987.

    Google Scholar 

  20. Chen LB. Mitochondrial membrane potential in living cells.Ann Rev Cell Biol 4: 155–181, 1988.

    CAS  PubMed  Google Scholar 

  21. Komori T, Matsui R, Adachi I, Shimizu T, Sueyoshi K, Narabayashi I.In Vitro Uptake and Release of201Tl and99mTc-MIBI in HeLa Cell.KAKU IGAKU (Jpn J Nucl Med) 32: 651–658, 1995.

    CAS  Google Scholar 

  22. Muriel DC, Anna S, Laurence DM, Caroline B, Jean-Claude K, Grgoire P, et al. Technetium-99m-Sestamibi Uptake by Human Benign and Malignant Breast Tumor Cells: Correlation with mdr Gene Expression.J Nucl Med 37: 286–289, 1996.

    Google Scholar 

  23. Ballinger JR, Bannerman J, Boxen I, Firby P, Hartman NG, Moore MJ. Technetium-99m-tetrofosmin as a substrate for P-glycoprotein:in vitro studies in multidrug-resistant breast tumor cells.J Nucl Med 37: 1578–1582, 1996.

    CAS  PubMed  Google Scholar 

  24. Piwnica-Worms D, Chiu ML, Budding M, Kronauge JF, Kramer RA, Croop JM. Functional imaging of multidrug resistant P-glycoprotein with and organotechnetium complex.Cancer Res 53: 977–984, 1993.

    CAS  PubMed  Google Scholar 

  25. Piwnica-Worms D, Holman BL. Noncardiac applications of hexakis(alkylsinonitrile)technetium-99m complexes.J Nucl Med 31: 1166–1167, 1990.

    CAS  PubMed  Google Scholar 

  26. Hendrikse NH, Franssen EJF, van der Graaf WTA, Meijer C, de Vries EGE. Reduced Tc-99m sestamibi accumulation in P-gp positive and MRP positive cell lines [Abstract].Proc Am Assoc Cancer Res 36: 358, 1995.

    Google Scholar 

  27. Nakagawa K, Yokota J, Wada M, Sasaki Y, Fujiwara Y, Sakai M, et al. Levels of glutathione S transferase πmRNA in human lung cancer cell lines correlate with the resistance to cisplatin and carboplatin.Jpn J Cancer Res 79: 301, 1998.

    Google Scholar 

  28. Kelley SL, Basu A, Teicher BA, Hacker MP, Hamer DH, Lazo JS. Over expression of metallothione in confers resistance to anticancer drugs.Science 241: 1813, 1998.

    Article  Google Scholar 

  29. Eijdems EW, De-Haas M, Coco-Martin JM, Ottenheim CP, Zaman GJ, Daumerse HG, et al. Mechanism of MRP over expression in four human lung cancer cell lines and analysis of the MRP amplication.Int J Cancer 60: 676, 1995.

    Article  CAS  PubMed  Google Scholar 

  30. Buscombe JR, Cwikla JB, Thakrar DS, Hilson AJ. Scintigraphic imaging of breast cancer: a review.Nucl Med Commun 18: 698–709, 1997.

    Article  CAS  PubMed  Google Scholar 

  31. Shih WJ, Rastogi A, Stipp V, Magoun S, Coupal J. Functional retention of Tc-99m MIBI in mediastinal lymphomas as a predictor of chemotherapeutic response demonstrated by consecutive thoracic SPECT imaging.Clin Nucl Med 23: 505–508, 1998.

    Article  CAS  PubMed  Google Scholar 

  32. Yamamoto Y, Nishiyama Y, Satoh K, Takashima H, Ohkawa M, Fujita J, et al. Comparative study of technetium-99m-sestamibi and thallium-201 SPECT in predicting chemotherapeutic response in small cell lung cancer.J Nucl Med 39: 1626–1629, 1998.

    CAS  PubMed  Google Scholar 

  33. Takekawa H, Takaoka K, Tsukamoto E, Kanegae K, Miller F, Kawakami Y. Thallium-201 Single Photon Emission Computed Tomography as an Indicator of Prognosis for Patients with Lung Carcionma.Cancer 80: 198–203, 1997.

    Article  CAS  PubMed  Google Scholar 

  34. Ichiya Y, Kuwabara Y, Otuka M, Tahara T, Yoshikai T, Fukumura T, et al. Assessment of response to cancer therapy using Fluorine-18-Fluorodeoxyglucose and positron emission tomography.J Nucl Med 32: 1655–1660, 1991.

    CAS  PubMed  Google Scholar 

  35. Shih WJ, Ryo UY, Dillon ML. Carbon-11-L-Methionine uptake with PET as a predictor of prognosis for bronchogenic carcinoma patients.J Nucl Med 30: 1420–1422, 1989.

    CAS  PubMed  Google Scholar 

  36. Kao CH, Chang-Lai SP, Chieng PU, Yen TC. Technetium-99m Methoxyisobutylisonitrile Chest Imaging of Small Cell Lung Carcinoma Relation to Patient Prognosis and Chemotherapy Response—A Preliminary Report.Cancer 83: 64–68, 1998.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiology, Osaka Medical College, 2-7, Daigakumachi, 569-8686, Takatsuki, Osaka, Japan

    Tsuyoshi Komori, Isamu Narabayashi, Ritsuo Matsui, Kozo Sueyoshi, Taizo Aratani & Keita Utsunomiya

Authors
  1. Tsuyoshi Komori
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Isamu Narabayashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ritsuo Matsui
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kozo Sueyoshi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Taizo Aratani
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Keita Utsunomiya
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Komori, T., Narabayashi, I., Matsui, R. et al. Technetium-99m MIBI single photon emission computed tomography as an indicator of prognosis for patients with lung cancer —Preliminaly report—. Ann Nucl Med 14, 415–420 (2000). https://doi.org/10.1007/BF02988286

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02988286

Key words

Search

Navigation